DER produces anti-cancer effects through several metabolic pathways, including inhibition of the IGF-1/PI3K/Akt/HIF-1α pathway which is used by cancer cells to promote proliferation and angiogenesis and inhibit apoptosis [35], [36], [37], [38], [39], [40], [41], [42]. This evidence concerns the gene AKT1 and cancer.